Ignite Creation Date:
2024-05-05 @ 4:41 PM
Last Modification Date:
2024-10-26 @ 9:23 AM
Study NCT ID:
NCT00295932
Status:
COMPLETED
Last Update Posted:
2018-11-20
First Post:
2006-02-23
Brief Title:
Bortezomib Rituximab Cyclophosphamide and Prednisone in Treating Patients With Relapsed or Refractory Indolent Non-Hodgkins Lymphoma
Sponsor:
Memorial Sloan Kettering Cancer Center
Organization:
Memorial Sloan Kettering Cancer Center
Key Dates - Follows AllAPIJSON File Order
Start Date:
2005-12-13
Start Date Type:
ACTUAL
Primary Completion Date:
2018-03-11
Primary Completion Date Type:
ACTUAL
Completion Date:
2018-03-11
Completion Date Type:
ACTUAL
First Submit Date:
2006-02-23
First Submit QC Date:
February 23 2006
Study First Post Date:
2006-02-24
Study First Post Date Type:
ESTIMATED
Results First Submit Date:
None
Results First Submit QC Date:
None
Results First Post Date:
2018-11-20
Results First Post Date Type:
ACTUAL
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
None
Disp First Post Date Type:
None
Last Update Submit Date:
2018-11-15
Last Update Post Date:
2018-11-20
Last Update Post Date Type:
ACTUAL